203 related articles for article (PubMed ID: 23703616)
1. The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.
Plitzko B; Ott G; Reichmann D; Henderson CJ; Wolf CR; Mendel R; Bittner F; Clement B; Havemeyer A
J Biol Chem; 2013 Jul; 288(28):20228-37. PubMed ID: 23703616
[TBL] [Abstract][Full Text] [Related]
2. Amidoxime reductase system containing cytochrome b5 type B (CYB5B) and MOSC2 is of importance for lipid synthesis in adipocyte mitochondria.
Neve EP; Nordling A; Andersson TB; Hellman U; Diczfalusy U; Johansson I; Ingelman-Sundberg M
J Biol Chem; 2012 Feb; 287(9):6307-17. PubMed ID: 22203676
[TBL] [Abstract][Full Text] [Related]
3. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.
Jakobs HH; Mikula M; Havemeyer A; Strzalkowska A; Borowa-Chmielak M; Dzwonek A; Gajewska M; Hennig EE; Ostrowski J; Clement B
PLoS One; 2014; 9(8):e105371. PubMed ID: 25144769
[TBL] [Abstract][Full Text] [Related]
4. The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.
Plitzko B; Havemeyer A; Kunze T; Clement B
J Biol Chem; 2015 Apr; 290(16):10126-35. PubMed ID: 25713076
[TBL] [Abstract][Full Text] [Related]
5. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
[TBL] [Abstract][Full Text] [Related]
6. Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC.
Havemeyer A; Grünewald S; Wahl B; Bittner F; Mendel R; Erdélyi P; Fischer J; Clement B
Drug Metab Dispos; 2010 Nov; 38(11):1917-21. PubMed ID: 20699408
[TBL] [Abstract][Full Text] [Related]
7. Defining the Role of the NADH-Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System.
Plitzko B; Havemeyer A; Bork B; Bittner F; Mendel R; Clement B
Drug Metab Dispos; 2016 Oct; 44(10):1617-21. PubMed ID: 27469001
[TBL] [Abstract][Full Text] [Related]
8. The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids.
Ginsel C; Plitzko B; Froriep D; Stolfa DA; Jung M; Kubitza C; Scheidig AJ; Havemeyer A; Clement B
Drug Metab Dispos; 2018 Oct; 46(10):1396-1402. PubMed ID: 30045842
[TBL] [Abstract][Full Text] [Related]
9. The mammalian molybdenum enzymes of mARC.
Ott G; Havemeyer A; Clement B
J Biol Inorg Chem; 2015 Mar; 20(2):265-75. PubMed ID: 25425164
[TBL] [Abstract][Full Text] [Related]
10. The fourth mammalian molybdenum enzyme mARC: current state of research.
Havemeyer A; Lang J; Clement B
Drug Metab Rev; 2011 Nov; 43(4):524-39. PubMed ID: 21942410
[TBL] [Abstract][Full Text] [Related]
11. Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2.
Sparacino-Watkins CE; Tejero J; Sun B; Gauthier MC; Thomas J; Ragireddy V; Merchant BA; Wang J; Azarov I; Basu P; Gladwin MT
J Biol Chem; 2014 Apr; 289(15):10345-10358. PubMed ID: 24500710
[TBL] [Abstract][Full Text] [Related]
12. The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues.
Krompholz N; Krischkowski C; Reichmann D; Garbe-Schönberg D; Mendel RR; Bittner F; Clement B; Havemeyer A
Chem Res Toxicol; 2012 Nov; 25(11):2443-50. PubMed ID: 22924387
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes.
Wahl B; Reichmann D; Niks D; Krompholz N; Havemeyer A; Clement B; Messerschmidt T; Rothkegel M; Biester H; Hille R; Mendel RR; Bittner F
J Biol Chem; 2010 Nov; 285(48):37847-59. PubMed ID: 20861021
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians.
Ott G; Reichmann D; Boerger C; Cascorbi I; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
Drug Metab Dispos; 2014 Apr; 42(4):718-25. PubMed ID: 24423752
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in
Rixen S; Havemeyer A; Tyl-Bielicka A; Pysniak K; Gajewska M; Kulecka M; Ostrowski J; Mikula M; Clement B
J Biol Chem; 2019 Nov; 294(46):17593-17602. PubMed ID: 31554661
[TBL] [Abstract][Full Text] [Related]
16. From the Eukaryotic Molybdenum Cofactor Biosynthesis to the Moonlighting Enzyme mARC.
Tejada-Jimenez M; Chamizo-Ampudia A; Calatrava V; Galvan A; Fernandez E; Llamas A
Molecules; 2018 Dec; 23(12):. PubMed ID: 30545001
[TBL] [Abstract][Full Text] [Related]
17. The Chlamydomonas reinhardtii molybdenum cofactor enzyme crARC has a Zn-dependent activity and protein partners similar to those of its human homologue.
Chamizo-Ampudia A; Galvan A; Fernandez E; Llamas A
Eukaryot Cell; 2011 Oct; 10(10):1270-82. PubMed ID: 21803866
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial amidoxime reducing component (mARC): involvement in metabolic reduction of N-oxides, oximes and N-hydroxyamidinohydrazones.
Jakobs HH; Froriep D; Havemeyer A; Mendel RR; Bittner F; Clement B
ChemMedChem; 2014 Oct; 9(10):2381-7. PubMed ID: 25045021
[TBL] [Abstract][Full Text] [Related]
19. Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC.
Schneider J; Girreser U; Havemeyer A; Bittner F; Clement B
Chem Res Toxicol; 2018 Jun; 31(6):447-453. PubMed ID: 29856598
[TBL] [Abstract][Full Text] [Related]
20. Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates.
Indorf P; Kubitza C; Scheidig AJ; Kunze T; Clement B
J Med Chem; 2020 Jun; 63(12):6538-6546. PubMed ID: 31790578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
